Results 251 to 260 of about 110,409 (295)
Some of the next articles are maybe not open access.

Peritoneal mesothelioma

Current Treatment Options in Oncology, 2000
Malignant peritoneal mesothelioma is an aggressive neoplasm that rapidly spreads within the confines of the abdominal cavity to involve most accessible peritoneal and omental surfaces. Current treatments are unsatisfactory, and new approaches are needed. We have noted prolonged survival in selected patients after intensive multimodality treatment.
R N, Taub   +4 more
openaire   +2 more sources

Pericardial Mesotheliomas

Advances in Anatomic Pathology, 2023
Primary pericardial mesothelioma (PM) is a rare tumor arising from the mesothelial cells of the pericardium. It has an incidence of <0.05% and comprises <2% of all mesotheliomas; however, it is the most common primary malignancy of the pericardium.
openaire   +2 more sources

Pleural mesothelioma

Current Opinion in Oncology, 1991
Pleural mesotheliomas are uncommon tumors that can be classified as localized or diffuse. Diffuse pleural mesotheliomas are invariably malignant. Although the frequency is low in the general population, it is more common in persons with a heavy occupational exposure to asbestos, and is considered as a signal tumor to asbestos exposure with medicolegal ...
openaire   +3 more sources

Peritoneal Mesothelioma

Radiology, 1978
Five cases of malignant peritoneal mesothelioma are reported. Its radiographic manifestations consisted of a desmoplastic mesenteric process with or without a localized mass displacing gastrointestinal structures. Appreciation of the nature of this tumor permits pathologic-radiologic correlation and an understanding of the radiographic changes.
M P, Banner, V K, Gohel
openaire   +2 more sources

Pleural Mesothelioma

The Annals of Thoracic Surgery, 1987
Pleural mesotheliomas are uncommon tumors. Correct diagnosis of the benign variant is rarely made preoperatively, and resection is the treatment of choice and is curative. Malignant pleural mesotheliomas are locally aggressive and difficult to treat. They may be seen clinically as localized pleural tumors or as diffuse pleural disease with effusion and
N, Martini   +5 more
openaire   +2 more sources

Peritoneal mesothelioma

Current Treatment Options in Oncology, 2002
Peritoneal mesothelioma is usually a rapidly fatal primary peritoneal surface malignancy with a median survival time of less than 1 year, mainly because of lack of effective treatment. The incidence is approximately one per 1,000,000; approximately one fifth to one third of all mesotheliomas are peritoneal.
Faheez, Mohamed, Paul H, Sugarbaker
openaire   +2 more sources

Malignant mesothelioma

Lancet, The, 2005
Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in frequency throughout the world. Although the main risk factor is asbestos exposure, a virus, simian virus 40 (SV40), could have a role. Mesothelioma has an unusual molecular pathology with loss of tumour suppressor genes being the predominant pattern of lesions,
Bruce W S, Robinson   +2 more
exaly   +3 more sources

Peritoneal mesothelioma

Human Pathology, 1977
The cytohistology in 82 cases diagnosed as malignant peritoneal mesothelioma was correlated with available clinical and gross pathologic information. The cases were then evaluated as to ceratainty of diagnosis. The material had come from a large number of sources, most of it having been traced by a history of occupational exposure to asbestos.
M, Kannerstein, J, Churg
openaire   +2 more sources

Peritoneal Mesothelioma

Current Treatment Options in Oncology, 2008
Malignant peritoneal mesothelioma (MPM) is an aggressive neoplasm that rapidly spreads within the confines of the abdominal cavity to involve most accessible peritoneal and omental surfaces. Current treatment options are unsatisfactory, and new approaches are needed.
Mary E, Hesdorffer   +3 more
openaire   +2 more sources

Malignant Pleural Mesothelioma

Journal of Clinical Oncology, 2009
Malignant pleural mesothelioma continues to be a challenge. The diagnosis and treatment of patients with malignant pleural mesothelioma requires a multidisciplinary approach. The diagnosis is best made by thoracoscopic biopsy and the aid of immunohistochemistry. Molecular studies identified inactivation of the neurofibromatosis-2 gene and INK4alpha/ARF
Anne S Tsao
exaly   +3 more sources

Home - About - Disclaimer - Privacy